Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells (Q28582485)

31 January 2017

title

Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells (English)

1 reference

31 January 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21111711

4 September 2024

author name string

Yunxia Zhu

1

1 reference

31 January 2017

Tingting Shu

2

1 reference

31 January 2017

Yan Lin

3

1 reference

31 January 2017

Hongdong Wang

4

1 reference

31 January 2017

Junwei Yang

5

1 reference

31 January 2017

Yuguang Shi

6

1 reference

31 January 2017

Xiao Han

7

1 reference

31 January 2017

language of work or name

English

0 references

publication date

7 January 2011

1 reference

31 January 2017

25 November 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21111711

full work available at URL

4 September 2024

https://api.elsevier.com/content/article/PII:S0006291X10021510?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

https://api.elsevier.com/content/article/PII:S0006291X10021510?httpAccept=text/plain

4 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Biochemical and Biophysical Research Communications

4 September 2024

published in

1 reference

31 January 2017

volume

404

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

159–165

1 reference

Diabetes and advanced glycation endproducts

31 January 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

4 September 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

4 September 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products

4 September 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

4 September 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

4 September 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

4 September 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products

4 September 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

4 September 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Beta-cell failure as a complication of diabetes

4 September 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells

4 September 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Gene silencing by adenovirus-delivered siRNA.

4 September 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

A simplified system for generating recombinant adenoviruses

4 September 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Prostaglandin E2 regulates Foxo activity via the Akt pathway: implications for pancreatic islet beta cell dysfunction

4 September 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Oxidative stress as a major culprit in kidney disease in diabetes

4 September 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro.

4 September 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis

4 September 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus

4 September 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis

4 September 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085

Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy

4 September 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.085